Active Yeast (Saccharomyces cerevisiae) 2026: Research, EU Regulation & Strain Science

1. Market Overview: Active Dry Yeast Continues to Lead the Feed Yeast Category

Saccharomyces cerevisiae is the most widely used and most extensively researched species among live active yeast products for animal feed globally, and it remains the only yeast species systematically recognized by major regulatory authorities such as the EU under the "gut flora stabilisers" functional category, with ongoing cross-species authorizations. Looking at the global feed yeast market as a whole, 2026 market size estimates range from USD 2.6 to 3.8 billion depending on methodology, with CAGR generally falling between 6% and 8%. Within this, active dry yeast continues to hold the leading product-type share, underpinned by its mature scientific evidence base and strong regulatory recognition.

2. Research Progress: Mechanistic Evidence Continues to Accumulate, Extending From Ruminants to Monogastrics and Companion Animals

Ruminants: A 2024 study published in BMC Veterinary Research found that feeding live yeast improved the performance of mid-lactation dairy cows by altering ruminal bacterial community composition, while simultaneously improving serum antioxidant capacity and immune response. Multiple meta-analyses have also continued to validate the positive effects of S. cerevisiae supplementation on ruminal fermentation parameters and milk yield in ruminants — across studies, average milk yield improvements range from 3.6% to 8%, with average dry matter intake improvements of approximately 2.5%.

Monogastric and Pseudo-Ruminant Species: A review published in January 2026 in Tropical Animal Health and Production systematically examined the evidence for live S. cerevisiae application in non-ruminant and pseudo-ruminant diets, noting that it enhances mucosal immunity by increasing IgM and IgA activity, supports intestinal development and function, adsorbs mycotoxins, modulates gut microbiota composition, and effectively reduces pathogenic bacteria counts.

Integrated Research Trends: A 2026 review published in the International Journal of Agriculture and Biosciences was among the first to integrate research evidence across three major yeast derivative categories — live yeast, yeast cell wall, and yeast hydrolysate — reflecting the field's shift toward a more systematic understanding of the broader yeast derivative functional spectrum.

3. Regulatory Developments: The EU Continues to Approve and Renew Multiple S. cerevisiae Strains, With Applications Expanding Into Companion Animals

The European Food Safety Authority (EFSA)'s scientific review activity for live S. cerevisiae feed additives has remained notably active between 2024 and 2026:

• In April 2026, EFSA published its latest efficacy assessment for an S. cerevisiae strain used in broiler chickens and other poultry species

• In April 2025, EFSA completed a renewal assessment for an S. cerevisiae strain used in dairy cows under the gut flora stabilisers functional category

• In 2024, several S. cerevisiae strains used in cattle for fattening and rabbits completed renewal assessments, confirming continued safety for target species, consumers, and the environment

• Notably, in 2023, an S. cerevisiae strain was submitted to EFSA for the first time for safety and efficacy assessment in cats and dogs — marking the extension of live S. cerevisiae applications into companion animal nutrition

• In January 2026, Commission Implementing Regulation (EU) 2026/168 formally confirmed the continued validity of analytical method assessment conclusions for another S. cerevisiae strain

These regulatory developments send a clear signal: in major markets such as the EU, the approval pathway for live S. cerevisiae additives has become a relatively mature, routine scientific review process — and the completeness and traceability of strain safety and efficacy data are core factors determining whether a product can maintain market access over time.

4. Application Trends: From Ruminant Rumen Health to Mucosal Immunity and Mycotoxin Binding in Swine and Poultry

Ruminants (Cattle & Sheep): Remains the application area with the most extensive evidence base, with core value centered on rumen microbiota stabilization, improved fiber digestion efficiency, and improved milk yield.

Swine, Poultry, and Other Monogastrics: Core value has expanded from improved feed intake toward enhanced mucosal immunity, intestinal development support, and mycotoxin adsorption.

Companion Animals (Pets): As a relatively emerging application area, live S. cerevisiae is gradually entering pet food formulation systems alongside advancing EU regulatory approval.

5. Competitive Landscape: Strain Specificity Becomes the Core Barrier

An important pattern emerges from actual EU regulatory approval practice: authorization of live S. cerevisiae additives is highly "strain-specific" — different specific strains within the same species must each submit separate safety and efficacy data for different target species and undergo independent review. This means strain selection capability and species-specific efficacy data accumulation constitute the core competitive barrier in this category — not simply production capacity or price competition.

For suppliers, this shapes the direction of differentiation: rather than pursuing a generalized "works for all species" positioning, it is more effective to pursue strain-specific efficacy validation targeted at particular species — especially in segments where research evidence remains comparatively underdeveloped, such as young ruminants, aquaculture, and companion animals.

6. Industry Pain Points & How Anqirui Addresses Them

Pain Point 1: Strain-specific efficacy makes generalized marketing claims difficult for professional customers to trust

Anqirui maintains product positioning and technical communication grounded in strain-specific, species-specific evidence, avoiding generalized "active yeast works for everything" messaging.

Pain Point 2: Viability is the key variable determining whether efficacy actually materializes

Anqirui continues to invest in strain tolerance screening and stabilization coating technology, ensuring viability is controllable and verifiable from the factory to actual feeding.

Pain Point 3: Efficacy data remains relatively limited in emerging application areas such as companion animals and aquaculture

Anqirui actively monitors research developments in these emerging areas, working to provide more targeted products and technical support for customers in these differentiated niche markets.

Pain Point 4: International buyers demand increasingly rigorous strain safety data and compliance documentation

Anqirui maintains a complete strain quality traceability system and can provide third-party test data to help customers navigate increasingly rigorous compliance requirements across different markets.

7. Industry Outlook

Live S. cerevisiae is in a steady growth phase underpinned by solid scientific evidence and a mature regulatory framework. Future competitive advantage will increasingly depend on two core capabilities: strain-specific data accumulation and viability assurance capability — rather than simple product availability alone.

References

1. Feeding live yeast (Saccharomyces cerevisiae) improved performance of mid-lactation dairy cows by altering ruminal bacterial communities and functions of serum antioxidation and immune responses, BMC Veterinary Research, 2024

2. Desnoyers M, et al. Meta-analysis of the influence of Saccharomyces cerevisiae supplementation on ruminal parameters and milk production of ruminants. Journal of Dairy Science, 2009

3. Saccharomyces cerevisiae as a probiotic feed additive to non and pseudo-ruminant feeding: a review, Tropical Animal Health and Production, 2026

4. Exploration of Saccharomyces cerevisiae as a Feed Additive: Live Yeast, Yeast Cell Wall and Yeast Hydrolysate, International Journal of Agriculture and Biosciences, 2026, 15(1)

5. EFSA Journal opinions and renewal assessments on various Saccharomyces cerevisiae strains for poultry, dairy cows, cattle for fattening, rabbits, and companion animals, European Food Safety Authority, 2024-2026

6. Commission Implementing Regulation (EU) 2026/168, Official Journal of the European Union, January 2026

7. Feed Yeast Market Size, Share, Growth, Trends 2026-2034, Fortune Business Insights